chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose, small amount dripped, received 90%; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix (intercostal). On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete dose administered. On an unknown date, the outcome of the incomplete dose administered was unknown.   Additional Information: GSK Receipt Date: 07-Jul-2022 Reporter's Comments:  Reporter stated that that the patient received the 2nd dose of Shingrix and whilst injecting a small amount dripped out and the patient felt did not received the full dose. Reporter reported that the patient received at least 90 percent of the dose. Pharmacist did not want to provide patient information. Additional supportive information As patient administered 90 percent of dose which led to incomplete dose administered.
after a second COVID 19 infection; after a second COVID 19 infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 2 diabetes" (unspecified if ongoing); "I dont exercise" (unspecified if ongoing); "COVID-19 infection" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "after a second COVID 19 infection". The patient underwent the following laboratory tests and procedures: Blood test: Not good, notes: My bloodwork isn't good. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient had Pfizer, his wife had Moderna. Patient did not exercise and his bloodwork was not good, type 2 diabetes etc. After a second COVID 19 infection both decided to use Paxlovid as per (withheld) and many others to help relieve symptoms.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300208142 same patient, different drug/event;US-PFIZER INC-202300208143 same reporter, different drug/event/patients;
Red, itchy area about 1 inch below injection site on left arm.  Area is not around the injection site, but near it. Patch is about 2 inches long and 1 inch wide.
Few hours after vaccine administered, patient inconsolable crying, vomited, fever (102), decreased PO intake, decreased urine output. Pt had to be given IV fluids. Then did well.
Fatigue, upper abdominal pain-lasting 3 days, mild headache, moderate pain in arm of injection, weakness, mild nausea. Due date-Jan 11th 2018.
fever to touch (all on the injection site); reddish spot /  (all on the injection site); swollen /  (all on the injection site); itching / (all on the injection site); rash on the elbow; This case was reported by a pharmacist via call center representative and described the occurrence of injection site warmth in a 63-year-old female patient who received Herpes zoster (Shingrix) (batch number 3C37A, expiry date 1st April 2022) for prophylaxis.   On 29th September 2020, the patient received the 1st dose of Shingrix (intramuscular). On 5th October 2020, 6 days after receiving Shingrix, the patient experienced injection site warmth, injection site erythema, injection site swelling, injection site itching and rash. On an unknown date, the outcome of the injection site warmth, injection site erythema, injection site swelling, injection site itching and rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site warmth, injection site erythema, injection site swelling, injection site itching and rash to be related to Shingrix.  Additional details were provided as follows: The patient after a week of receiving first dose of Shingrix experienced itching, swollen, reddish spot, fever to touch (all on the injection site) and rash on the elbow. The reporter mentioned that all the adverse events were ongoing as they all started on 5th October 2020.  The reporter consented to follow up.
Within 3-5 minutes patient lightheaded, "panic attack" - nervous. Had her to sit down. Gave water, crackers. Over 10-15 minutes elevated BP. Pt said she has panic attacks. No breathing difficulty.
23 yom with pmh of moderate asthma presents to the hospital on 8/15 complaining of chest discomfort transferred from outside hospital.  Reports he was in his normal state of health when 2 days prior to admission he had his second dose of modern vaccine.  The subsequent day he had a normal side effect of fevers chills and he and his girlfriend felt diffuse chest pressure throughout the chest.  His girlfriend got better the next day, however the patient started complaining of sharp chest pain in the mid to left chest area that improved after he laid down and took deep breaths.  Subsequently he decided to wait until 48 hours after the second vaccine dose and if continues to have problems with go to the hospital for assessment.  On the day of admission, on awakening from sleep the patient felt severe left arm soreness and then upon standing up felt severe sharp pain in his left chest and therefore decided to go to the hospital for assessment.  He also reported nausea and vomiting since 1 day prior to admission.  Reports episodes of chills and shortness of breath as well.  He was tested for COVID-19 at the outside hospital which was negative.  Had positive troponin, elevated CRP and ESR upon presentation.  Cardiology was consulted and  recommended continuing telemetry monitoring, an echocardiogram, and empiric ibuprofen 600 mg every 8 hours in the absence of hemodynamic compromise.   He was given 2 doses of PRN nitroglycerin for chest pain during his hospitalization without relief, which was then followed with an IM dose of toradol.  He does have a strong family history of heart disease; however, the patient's symptoms did not suggest an ischemic syndrome per cardiology notes.  On the day of discharge (8/16), patient was chest pain-free, had no shortness of breath, and echocardiogram was negative for any wall motion abnormalities and showed a normal EF.  Patient was discharged in stable condition home with plan to follow-up outpatient with cardiology in 1-2 weeks  and to obtain a cardiac MRI as an outpatient.
@ 1230PM went home ate then noticed a localized rxn on arm & leg swelling; Was taken to MD & given DPH;
14days p/vax pt devel 4-5 papular lesions,  on 17feb pt had 20-40 lesions & was dx as having chickenpox, treated w/acyclovir. pt eventually devel 100-200 lesion & temp 104f. addl info requested
pt recvd vax early AUG94 & 2wks p/vax exp tremors & felt as if head was going to explode;30SEP94 pt exp same sx as well as nausea,diarrhea,tingling in arms;
Near miss: we had a pharmacist almost dispense this as a Tetanuse Toxoid vaccine. Labeling confusion on this box as tetanus toxoid i just a conjugate.
red mark at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red mark at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 008D21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.   On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red mark at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red mark at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No information about treatment medication was provided by reporter.   This case was linked to MOD-2021-263826 (Patient Link).
Information has been received from a health care professional concerning a 57 year old female who in approximately, 1987, was vaccinated with 1 dose of pneumonococcal vaccine 23 polyvalent and subsequently, the pt experienced an injection site reaction with noted redness and a rash. Follow-up information from a physician indicated that there was "no adverse reaction to the best of our knowledge." No further information is available.
pt recv 1st dose JUL98 & did not recv 2nd dose until NOV98 & 16DEC98 pt hep b antibody titer was 0.9;
BY the evening I developed a headache and had serve  pain for about 5 days in the middle of my back. After that my nose got stocked up and I ended up getting Covid.
12 days after receiving shot 1 of the Moderna COVID 19 vaccine, I experienced full-body hives covering my entire body (including face, hands and feet).  Heaviest activity is on my arms, legs, and torso.  These hives come and go, though never truly disappear.  They continue today, 4 months after vaccination.  I have sought treatment at primary care physicians, dermatologists, and now finally have an allergist who is helping to treat using Xolair to try and bring the urticaria under control.  Benadryl, Hydroxyzine, Singulair, and creams were all tried but did not work.
Both knees hurt and had pain. Both wrist (back side of thumb) hurt /pain. Had fatigue for 3 days. Had the moderna vaccine.  Felt strange for 3 days. No energy
Rash that is itchy and raised. Starting on arms clearing, starting on head and chest then clearing slightly, currently on stomach, back, legs, arms. Ongoing since 11/1/21.
bad stomach ache; too sick; back ache; nauseated; fever; felt as something was crawling underneath her skin; This spontaneous case was reported by a consumer and describes the occurrence of FORMICATION (felt as something was crawling underneath her skin), ABDOMINAL PAIN UPPER (bad stomach ache), ILLNESS (too sick), BACK PAIN (back ache) and NAUSEA (nauseated) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer.    On 14-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Dec-2021, the patient experienced FORMICATION (felt as something was crawling underneath her skin) and PYREXIA (fever). On 15-Dec-2021, the patient experienced ABDOMINAL PAIN UPPER (bad stomach ache), ILLNESS (too sick), BACK PAIN (back ache) and NAUSEA (nauseated). At the time of the report, FORMICATION (felt as something was crawling underneath her skin), ABDOMINAL PAIN UPPER (bad stomach ache), ILLNESS (too sick), BACK PAIN (back ache), NAUSEA (nauseated) and PYREXIA (fever) outcome was unknown.            No concomitant medications or treatment details were reported.  The patient was reported to have received 2 doses (dose 1 and dose 2) of Moderna vaccine already.
following day after vaccine I woke with with moderate headache  hip , joint and muscle pain. 1/4 the pain went away. on 1/6 the pain has came back and it is more severe. I called employee health and I am waiting on call back from them.
Syncope after vaccine. Writhing of (L) arm (arm received vaccines). < 1 min, hypotension, bradycardia to 50's pt c/o tingling, nausea -> pt continued to feel vertigo & nausea BP remained (on HR 50s after 60 mins transferred to another clinic.
Pt stated she felt tightness and pain in her chest immediately after receiving hepatitis B vaccine, in which that was the last injection given. A second set of vitals were taken and were normal, Dr was informed, pt was monitored for 15 min.
Has a 100.0 fever, chills, headache, body ache, and soreness at injection site.; Has a 100.0 fever, chills, headache, body ache, and soreness at injection site; Has a 100.0 fever, chills, headache, body ache, and soreness at injection site; Has a 100.0 fever, chills, headache, body ache, and soreness at injection site; Has a 100.0 fever, chills, headache, body ache, and soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site.), CHILLS (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site), HEADACHE (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site), MYALGIA (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site) and INJECTION SITE PAIN (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site.), CHILLS (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site), HEADACHE (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site), MYALGIA (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site) and INJECTION SITE PAIN (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site). At the time of the report, PYREXIA (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site.), CHILLS (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site), HEADACHE (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site), MYALGIA (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site) and INJECTION SITE PAIN (Has a 100.0 fever, chills, headache, body ache, and soreness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 100 (Inconclusive) 100.0.         Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 19APR2021, No new information and patient stated that she was feeling fine.
Mom noticed swelling to area at injection site. No fever. Placed warm compress on it & administered Tylenol. Patient had a localized reaction to vaccine. Reddened area around injection site.
Pain Flareup.  Pins and needles, numbness, sharp pain in feet, arms and hands.  Treatment included two rounds  of  Prednizone 4mg pack over six days starting on June 3, 2021.  Moderate improvement noted. Second dose of Presnizone started on June 18, 2021 for six days. Mild improvement noted. On June 23, 2021 trigger point injections for pain received. I am still experiencing elevated pain levels. I am being treated for Plantar Fascitis in my right foot. Sharp pain persists despite treatment with physical therapy, stretching exercises and ice.
Information has been received from a physician concerning a female (age not reported) who was vaccinated with a dose of GARDASIL (lot not reported). Subsequently the patient developed warts on her back after vaccination. It reported that the patient implied the patient was not sexually active. The warts were treated topically. The patient's warts persisted. Additional information has been requested.
Patient 1st complained on 11/16/06 of severe pain in her right arm, which had spread to her neck and couldn't move her arm above shoulder level.  She still complains on 11/22 of not being able to lift her arm after 2 weeks of receiving the injection.
No Adverse Event; I was supposed to have a Moderna booter. I have symptoms from Pfizer.; At the booster clinic i was asked If i get Moderna or Pfizer. I n told them Moderna. Hmm I think they messed up; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (I was supposed to have a Moderna booter. I have symptoms from Pfizer.), PRODUCT CONFUSION (At the booster clinic i was asked If i get Moderna or Pfizer. I n told them Moderna. Hmm I think they messed up) and NO ADVERSE EVENT (No Adverse Event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   In November 2021, the patient received third dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced WRONG PRODUCT ADMINISTERED (I was supposed to have a Moderna booter. I have symptoms from Pfizer.) and PRODUCT CONFUSION (At the booster clinic i was asked If i get Moderna or Pfizer. I n told them Moderna. Hmm I think they messed up). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). The patient was treated with IBUPROFEN at an unspecified dose and frequency and TRAMADOL for Pain, at an unspecified dose and frequency. At the time of the report, WRONG PRODUCT ADMINISTERED (I was supposed to have a Moderna booter. I have symptoms from Pfizer.), PRODUCT CONFUSION (At the booster clinic i was asked If i get Moderna or Pfizer. I n told them Moderna. Hmm I think they messed up) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.            Concomitant medication was not reported.  Patient received two previous doses of Moderna vaccine in January and experienced COVID-19. Two weeks ago, in Nov-2021, patient received Pfizer booster dose. Patient was supposed to have Moderna booster dose but received Pfizer dose. Patient was asked at booster clinic whether patient received Moderna or Pfizer dose? Patient replied Moderna. Patient think clinic had messed up vaccine. After receiving booster dose patient had terrible thigh, knee and calf pain. Tingling in foot. Ultrasound was performed showed no clots. Patient's lymph nodes of right side of neck popped up and neck was stiff. Patient's right leg was very painful. Patient cannot bear weight. Patient had Ibuprofen but it did not help. Patient's doctor prescribed small dose of Tramadol to get through this pain. Patient was nervous about stiffness and health.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-620777 (Patient Link).
woke up 4/7/21 with abdominal pain  went to urgent care and then emergency room 4/8/21 diagnosed with appendicitis after a CT scan.  had appendectomy 4/9/21 stayed in hospital recovering until 4/10/21
Father falsified DOB on form.  Stated patient's DOB was date.  Rph discovered actual DOB is date after shot was administered.
Inflamed lymph node behind collarbone (between collarbone and trapezius muscle. Size of a marble that is hard and moveable. First noticed on 5/8/21, four days after first shot of the Pfizer vaccine. No noticeable symptoms, like fatigue, or pain caused by swollen lymph node yet. Swelling has not gone down as of 5/14/21.
Throat pain; Headache; Fatigue; Pain in both wrists; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat pain), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Pain in both wrists) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Throat pain), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Pain in both wrists). At the time of the report, OROPHARYNGEAL PAIN (Throat pain), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Pain in both wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. No concomitant medication was reported
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On 21-JUL-2016, the patient was vaccinated with improperly stored ROTATEQ lot # L035510 with expiry date: 13-MAY-2017 (dosing details were not reported). It was reported that the vaccines were exposed to the temperature of 0.0 C during a time frame of 13 hours and 45 minutes. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Red, warm area of upper arm on left, 6 cm. No fevers or other symptoms.
EXTENSIVE LOCAL REACTION (ERYTHEMA, INDURATION, WARMTH), WITH SURROUNDING MACULOPAPULAR RASH, THAT SPREAD THE NEXT DAY TO THE WHOLE BODY.
My mensural cycle is not normal like it was before.  My tendons and joints seem to be more irritated then before the vaccination.
0N 8/14/2020 PATIENT'S MOM CALLED OUR OFFICE CONCERNED ABOUT POSSIBLE SHOT REACTION. LARGE RED AREA AROUND SITE AND HOT TO TOUCH. AN APPOINTMENT FOR EVALUATION WAS  SCHEDULED. PT CAME IN 8/14/2020 AND WAS DIAGNOSED WITH ADVERSE EFFECT OF OTHER  BACTERIAL VACCINES (BEXSERO LOCAL REACTION, WITH ERYTHEMA, SWELLING, AND PAIN)  AFTER THIS APPOINTMENT THERE WERE NO CALLS BACK FROM PATIENT WITH WORSENING  CONDITIONS. PATIENT RECIEVED HER SECOND BEXSERO VACCINE ON 10/14/2020.
1st noticed elevated temp then rapid heart rate becoming more pronounced; went to ER about 1230AM; 17OCT91 w/inc temp, inc HR, inc BP & wheezing; EKG done; given DPH & APAP sx resolved but admitted for observatin until next AM;
Narrative: 72 yo male patient died on 02/16/2022 at unknown place & unknown cause. Pt did not die at facility. Last chart note from mental health MD on 10/25/2021. Pt had received a covid vaccine on 4/1/21. See pt's problem list in pt's chart: 16 Active Problems PROBLEMS LAST MOD PROVIDER Generalized anxiety disorder 12/01/2020, Mild cognitive impairment 05/11/2020 Due to Cerebral Atherosclerosis, qualitatively exacerbated by Depression Hypertensive disorder. Foreign body in stomach Obstructive Sleep Apnea 09/29/2014; Alcohol Dep-Remission 06/10/2010; Foot Pain 01/06/2009; DM Type II Dm W/O 03/17/2008 complications; CHF* 03/17/2008; Dysthymia 11/04/2019; Persistent Depressive Disorder, with Intermittent Major Depressive Episodes; Hyperlipidemia* 09/13/2007; DJD* 09/13/2007; Chronic recurrent major 08/28/2018 depressive disorder; Psoriatic arthritis; Hypertension 11/30/2020; Likely pt's death is not related to the covid vaccine given pt's advanced age, comorbidies, and long length of time between death & date of vaccine administration.
Recipient states she had fever, chills the first night; woke up with "red, irritated" eyes on 05/27/21. Reports small drainage on both eyes. Denies any seasonal allergies and states this is "unusual" for her.
Sweats 20 mins. after vaccine. Had a sensation of something traveling across his back from right to left once while driving home. Next day had body aches, wheezing/cough, half dollar size spot at injection site that had dark and light patches.